# Intravenous Ibuprofen Versus Ketorolac in Bariatric Surgery

> **NCT05801900** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 116 (estimated)

## Conditions studied

- Postoperative Pain
- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Ketorolac group
- **DRUG:** Ibuprofen group

## Key facts

- **NCT ID:** NCT05801900
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05801900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05801900, "Intravenous Ibuprofen Versus Ketorolac in Bariatric Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05801900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*